Prenetics Global achieved breakthrough growth in 2025 financial performance, with revenue of approximately $92 million, primarily driven by IM8, its consumer-focused nutritional supplement brand. The brand achieved annual recurring revenue of $120 million, growing from approximately $581,000 in the first month to monthly revenue of approximately $10 million in December. IM8 brand's gross margin for the year was 63%, and the company projects 2026 revenue of $180 million to $200 million, with gross margins reaching or exceeding 60%. Management has divested non-core assets and currently holds approximately $160 million in liquid assets with no debt, targeting profitability by Q4 2027.
Prenetics Global achieved breakthrough growth in 2025 financial performance, with revenue of approximately $92 million, primarily driven by IM8, its consumer-focused nutritional supplement brand. The brand achieved annual recurring revenue of $120 million, growing from approximately $581,000 in the first month to monthly revenue of approximately $10 million in December. IM8 brand's gross margin for the year was 63%, and the company projects 2026 revenue of $180 million to $200 million, with gross margins reaching or exceeding 60%. Management has divested non-core assets and currently holds approximately $160 million in liquid assets with no debt, targeting profitability by Q4 2027.